MHS552

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MHS552, covering 2024-10-09 to 2024-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE) [Phase 1]